074430 — AMINOLOGICS CO Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for AMINOLOGICS CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5,360	-7,282	2,436	-1,620	3,522
Depreciation
Amortisation
Non-Cash Items	-639	15,760	754	3,466	805
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,064	-3,603	-3,855	5,155	-2,275
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	936	5,226	-218	7,466	2,541
Capital Expenditures	-662	-503	-156	-512	-45.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	29.5	-332	0	45.8	-14,762
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-632	-835	-156	-466	-14,807
Net Issuance / Retirement of Debt
Cash from Financing Activities	-164	-191	-224	-227	19,705
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	281	3,877	-740	6,884	7,574